An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer

Conditions:   Prostate Cancer;   Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions:   Drug: AZD4635;   Drug: Oleclumab;   Drug: Durvalumab Sponsor:   AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials